Sunday, August 10, 2014

Hot Low Price Companies To Buy Right Now

Our latest featured stock is recommended based on its low price to book value ratio; the company recommendation is a leading provider of helicopter services to the worldwide energy industry, explains J. Royden Ward, editor of Cabot Benjamin Graham Value Investor.

Based in Houston and founded in 1969, Bristow Group (BRS) has major transportation operations in the US Gulf of Mexico and the North Sea.

Bristow also operates in most of the other major offshore oil and gas producing regions of the world, including Alaska, Australia, Brazil, Mexico, Nigeria, Russia, and Trinidad.

Additionally, the company is a leading provider of production management services for oil and gas production facilities in the US Gulf of Mexico.

Revenues climbed 11% and EPS surged 58% during the 12 months ended December 31, 2013. Demand for helicopter services in the Gulf of Mexico is picking up and sales in Europe and West Africa are becoming strong.

Fourth quarter earnings were hurt by delayed orders, which spilled over into the 2014 first quarter. The company has begun a huge new contract with the United Kingdom where it will conduct all search and rescue operations.

Top Airline Companies To Invest In Right Now: Galectin Therapeutics Inc (GALT)

Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc., incorporated on January 26, 2001, is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be used in the treatment of liver fibrosis and fatty liver disease. These two compounds are produced from different natural starting materials, both possessing the property, which lends itself to binding to and inhibiting galectin proteins. GM-CT-01, the Company's product candidate for cancer therapy, is a linear polysaccharide polymer consisted of mannose and galactose that has a defined chemical structure and is derived from a plant source. GR-MD-02, the Company's product for treatment of liver fibrosis and fatty liver disease with inflammation and fibrosis, is a polysaccharide polymer possessing both linear and globular structures, which also is derived from a plant source.

GM-CT-01 has in development for the therapy of colorectal cancer and is in a Phase I/II clinical trial as a combination therapy with a tumor vaccine in patients with advanced melanoma. Based on the completed Phase I and partially completed Phase II clinical trials, the Company is exploring two additional potential indicia for the use of GM-CT-01 in combination with cancer chemotherapy. There are two additional pathways for the development of GM-CT-01 for use in treatment of cancer. GM-CT-01 was found to be generally safe when studied in a Phase I clinical trial in end-stage cancer patients with multiple tumor types alone and in combination with 5-Fluorouracil (5-FU), which is an Food and Drug Administration (FDA)-approved chemotherapy used for treatment of various types of cancer.

Advisors' Opinion:
  • [By Roberto Pedone]

     

    Galectin Therapeutics (GALT) offers drug research and development to create new therapies for fibrotic disease and cancer. This stock closed up 9.6% to $12.06 in Monday's trading session.

     

    Monday's Volume: 674,000

    Three-Month Average Volume: 222,171

    Volume % Change: 149%

     

    Shares of GALT jumped higher on Monday after Ascendiant initiated coverage on the stock with a buy recommendation.

     

     

    From a technical perspective, GALT spiked sharply higher here with strong upside volume. This stock has been uptrending for the last three months, with shares ripping higher from its low of $3.95 to its recent high of $13.21. During that move, shares of GALT have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GALT within range of triggering a near-term breakout trade. That trade will hit if GALT manages to take out Monday's high of $12.44 and then once it clears its 52-week high at $13.21 with high volume.

     

    Traders should now look for long-biased trades in GALT as long as it's trending above some near-term support levels at $11 or at $10 and then once it sustains a move or close above those breakout levels with volume that hits near or above 222,171 shares. If that breakout hits soon, then GALT will set up to enter new 52-week-high territory above $13.21, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.

     

Hot Low Price Companies To Buy Right Now: Holly Energy Partners L.P. (HEP)

Holly Energy Partners, L.P. operates a system of petroleum product and crude oil pipelines, storage tanks, distribution terminals, and loading rack facilities. As of December 31, 2009, its pipeline assets included approximately 820 miles of refined product pipelines that transport gasoline, diesel, and jet fuel in the metropolitan and rural areas of Texas, New Mexico, Arizona, Colorado, Utah and northern Mexico; approximately 510 miles of refined product pipelines that transport refined products in Texas and Oklahoma; 3 parallel 65 mile pipelines that transport intermediate feedstocks and crude oil to petroleum refinery facilities; approximately 960 miles of crude oil trunk, gathering, and connection pipelines located in west Texas, New Mexico, and Oklahoma that deliver crude oil to refineries; approximately 10 miles of crude oil and refined product pipelines in Salt Lake City, Utah; and gasoline and diesel connecting pipelines located in Tulsa, Oklahoma. The company?s ref ined product terminals and refinery tankage assets comprised four refined product terminals with an aggregate capacity of approximately 1,000,000 barrels in Texas, New Mexico, and Arizona; three refined product terminals with an aggregate capacity of approximately 500,000 barrels in Idaho and Washington; one refined product terminal with a capacity of 120,000 barrels in Idaho; two refined product terminals with aggregate capacity of 480,000 barrels in Texas; a refined product truck loading rack facility; a jet fuel terminal; on-site crude oil tankage having an aggregate storage capacity of approximately 600,000 barrels; and on-site refined product tankage having an aggregate storage capacity of approximately 1,400,000 barrels. HEP Logistics Holdings, L.P. serves as general partner of the company. Holly Energy Partners was founded in 2004 and is based in Dallas, Texas.

Advisors' Opinion:
  • [By Aimee Duffy]

    Master limited partnerships are not like other stocks, and the metrics we use to compare an MLP to its peers differ from the metrics we use to compare regular companies. For example, instead of the traditional P/E ratio, we emphasize MLP-specific metrics like distribution coverage ratio, and today's focus: price to distributable cash flow (P/DCF). I'll use MPLX (NYSE: MPLX  ) , Tesoro Logistics (NYSE: TLLP  ) , and Holly Energy Partners (NYSE: HEP  ) as our three examples.

  • [By Tyler Crowe]

    Let's face it, building pipeline to move oil and gas takes a long time, and several refiners and exploration and production companies just can't wait around for these pipes to get built. That is a large reason why HollyFrontier (NYSE: HFC  ) just announced that it and its midstream subsidiary Holly Energy Partners (NYSE: HEP  ) plan to add rail capacity of 70,000 barrels per day to its operations to move oil from Holly Energy's pipes in Southeast New Mexico to HollyFrontier's refining facilities in the region.�

  • [By Robert Rapier]

    The refinery logistics segment has done quite well, even when the associated refiner has struggled a bit. We like�Holly Energy Partners�(NYSE: HEP) for the long haul. I covered the partnership in some depth in�Holy Holly, What a Deal.

Hot Low Price Companies To Buy Right Now: Planet Platinum Ltd (PPN)

Planet Platinum Limited is an Australia-based company engaged in the operation of Showgirls Bar 20 and the on-going rental of property in Elsternwick. The Company operates in two segments: hospitality and entertainment and property rental businesses. The Company�� hospitality and entertainment segment comprises operations of Showgirls Bar 20 in Melbourne and is engaged in the nightclub through the provision of beverages and adult entertainment. Property segment comprise maintaining of rental property at Home Street, Elsternwick. The Company continues to receive lease rentals from its Home Street property. The investment property is located at 12 Home Street, Elsternwick Victoria. Advisors' Opinion:
  • [By Tabitha Jean Naylor]

    Americans consume a lot of chicken. It estimated that Americans consume about 81 pounds of poultry per year, per capita. With there being upwards of 310 million people living in the United States, it is no wonder why poultry production is big business. Two of the biggest names in poultry production are Tyson Foods (NYSE: TSN) and Pilgrim's Pride (NASDAQ: PPN).

Hot Low Price Companies To Buy Right Now: Endeavor IP Inc (ENIP)

Endeavor IP, Inc., formerly Finishing Touches Home Goods Inc., incorporated on December 8, 2009, is an integrated consulting firm that assists individuals, organizations, companies and government agencies in finding solutions to home and workplace-related barriers for seniors and people with disabilities, as well as ergonomics consultancy. The Company�� focused on providing services and products that helps to create barrier-free homes and workplace environments. The Company provides consulting services, including site audits and accessibility/ergonomic planning and development; installation and sales of accessibility, ergonomic and safety products, ergonomic consultancy for homes and businesses. During the fiscal year ended October 31, 2012, the Company focuses on providing services in two main areas: Accessibility and Ergonomics in the workplace and at home.

The Company offer functional assessment services for commercial and residential properties and offer recommendations based on its assessment to improve accessibility and safety of these sites. The Company offers its clients practical ergonomic solutions by offering consulting services, such as Ergonomic Assessments, Physical Demands Assessments, Disability Management / Return to Work, and Occupational Health and Safety. The Company�� consulting services include Workplace Risk Assessments, Office Layout, New Equipment Selection, Display Screen Equipment (DSE) Assessments, Accessibility and Disability Access Audits, Retail Ergonomics and Ergonomics Standards.

Advisors' Opinion:
  • [By James E. Brumley]

    They say a company is judged by the company it keeps. What's less said - though never disputed - is that a company is equally judged by the kind of talent it can attract... winning people tend to only work for winning companies. In that light, the fact that the newest chief of Endeavor IP Inc. (OTCBB:ENIP) is a former executive from the ranks of Rambus Inc. (NASDAQ:RMBS) and Tessera Technologies, Inc. (NASDAQ:TSRA) should underscore just how seriously the market should be taking ENIP. RMBS and TSRA didn't become large powerhouses by hiring folks who don't know what they're doing, and conversely, the fact that a former Rambus and Tessera Technologies guy was willing to step into the unknown and take the helm at Endeavor IP speaks volumes about the potential of the young company's IP portfolio.

  • [By Bryan Murphy]

    The winds of change are blowing within the patent-enforcement world. If you don't believe it, just ask Google Inc. (NASDAQ:GOOG), Akamai Technologies, Inc. (NASDAQ:AKAM), and Soverain Software LLC. All three companies recently found themselves on the losing end of a court decision - the appeals court, to be specific - that likely could have come out very differently were we in the patent-enforcement environment from just a couple of years ago. Things are a bit tougher for patent owners now. That change, however, may be a very good thing for patent-protection company Endeavor IP Inc. (OTCBB:ENIP) and ENIP shareholders.

  • [By John Udovich]

    Small cap patent stocks Spherix Inc (NASDAQ: SPEX), PDL BioPharma Inc (NASDAQ: PDLI) and Endeavor IP Inc (OTCBB: ENIP) are among the�growing number of publicly traded�US entities focused on collecting and making money from various types of patents. After all, monetizing patents can lead to incredible returns. For example: Nomura analyst Rick Sherlund wrote in a research note back in November that Microsoft Corporation (NASDAQ: MSFT) is generating $2 billion per year in revenue from Android patent royalties and he�estimates that this revenue has a 95% margin. However, there are risks associated with investing in stocks that invest in patents because a bi-partisan bill called the Innovation Act (H.R. 3309) is�working its way through Congress to try and reign in the activities of so-called�"patent trolls" or rather companies that buy or license patents from others.

No comments:

Post a Comment